The Business
BioSyent is a Canadian specialty pharmaceutical company focused on sourcing, commercializing, and further develop niche pharmaceutical and healthcare products with peak sales of <$20 million that are not yet available in Canada but is commercialized in other countries. This strategy has a number of advantages:
- No expensive pharmaceutical research and development costs
- Product’s effectiveness and safety is well documented in countries where it’s commercialized
- Niche markets with <$20 million potential sales do not attract large investments for research and development of new products, so conventional products in the space gain/lose market share purely